GALECTIN THERAPEUTICS INC (NASDAQ:GALT) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.
GALECTIN THERAPEUTICS INC's stock currently trades at $3.17 with a market capitalization of $369.9M. The Healthcare company's stock moved following the disclosure.